ClinicalTrials.gg
RecruitingNCT05066763Updated Oct 4, 2021

Parkinson's Foundation Surveys

An observational study in Parkinson Disease, sponsored by Parkinson's Foundation. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-10-04.

Sponsored by Parkinson's Foundation · Observational

How we know

From the registry’s dates

  • Started Apr 2021; still recruiting 5 years 7 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
1,000,000
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 1,650 studies in Parkinson Disease with a site in United States — 305 open to participants now, 387 under way, 7 of them phase 3. Parkinson Disease · United States.

Planned enrollment
Largest of 379
1,000,000 · median 78
Started
2021
with 103 others
Observational
381 of 1,650
75 open now
Primary completion
2030-12
later than 363 of 384 live
Registered
1,200th of 1,650
by date

Among the 1,650 studies in Parkinson Disease with a site in United States, this one has the largest planned enrollment of the 379 observational ones that give a count, is one of 104 that started in 2021, is one of 381 observational ones, reaches primary completion later than 363 of the 384 other live ones, and was the 1,200th registered.

Parkinson Disease

4,583 studies on the registry are indexed under Parkinson Disease; 1,086 are open to participants now.

Browse Parkinson Disease studies →

Open to participants now

305 of the 1,650 studies in Parkinson Disease with a site in United States are open now. Recruiting first, the newest first:

300 more — sign in →

All 305 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 752 Parkinson Disease studies recruiting now, 314 (42%) set no upper age limit and 127 (17%) stop at 75 or younger; 64 take children under 18; 189 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 1,650 studies in Parkinson Disease with a site in United States, or all of them as a file.
02

Study summary

Parkinson's Foundation Surveys is an initiative seeking to periodically survey people with Parkinson's disease (PD), their care partners and medical professionals to better understand specific aspects of living with PD.

03

Conditions studied

  • Parkinson Disease

Browse trials for

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

People with Parkinson's disease, care partners of people with Parkinson's disease, health professional that treats people with Parkinson's disease

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Willingness to be contacted by the Parkinson's Foundation for surveys and any future research opportunities
  • Anyone who self-reports that they have a diagnosis of Parkinson's disease
  • Care partner of a person with Parkinson's disease
  • Any health professional that regularly works with people with Parkinson's disease
  • 18 years of age or older

Exclusion criteria

Exclusion Criteria:

  • People who report that they do not have a diagnosis of Parkinson's disease, are not a care partner to someone with PD or do not work with people with PD in the health setting
  • An individual younger than 18 years of age
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
1,000,000 participants (estimated)
Target follow-up
10 Years
Patient registry
Yes

Groups and cohorts

  • People with Parkinson's disease

    Other: Non-interventional

Interventions

  • OtherNon-interventional

    non-interventional

06

What researchers measure

Primary outcomes

  1. Total number of survey respondents

    Total number of survey participants who consent into the study

    Time frame: 10 years

07

Study locations

1 of 1 sites recruiting
  • Parkinson's Foundation
    Miami, Florida 33131, United States
    Recruiting
    • Megan Feeney, MPH · Contactmfeeney@parkinson.org · 646-388-7674
    • James C Beck, PhD · Principal investigator
08

References and documents

Individual participant data

Plan to share: Yes — De-identified and coded survey responses may be shared with other researchers.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2021 (actual). Primary completion is estimated for Dec 2030, 116 months after the start.

Of 381 non-industry observational studies under Parkinson Disease, half reached primary completion within 48 months of starting (the median), counting those still running; a quarter within 22 and three quarters within 133. This study's planned 116 months is above that.

Counting every sponsor, half of 441 studies reached it within 47 months; a quarter within 22 and three quarters within 114.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 23, 2021
First posted
Oct 4, 2021
StartActual
Apr 2, 2021
Primary completionEst.
Dec 2030
CompletionEst.
Dec 2030
Last update
Oct 4, 2021
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 4, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05066763
Lead sponsor
Parkinson's Foundation
Responsible party
Sponsor
First posted
Oct 4, 2021
Start date
Apr 2, 2021
Primary completion
Dec 2030 (estimated)
Completion
Dec 2030 (estimated)
Last update
Oct 4, 2021

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion